| Value | ₹50.00 Cr |
|---|
NSE filing, NSE: MANORAMA. Summary written from the filing by ALFA Finder's alert engine.
Manorama Industries Ltd: key numbers
- Share price
- ₹1,788.20
- Market cap
- ₹11,288 Cr
- Revenue (annual)
- ₹1,367 Cr
- Net profit (annual)
- ₹224.9 Cr
- P/E (TTM)
- 45.8×Sector 27.1×
- Promoter holding
- 51.38%-2.94% QoQ
- FII holding
- 4.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manorama Industries Ltd
All →Manorama Industries Annual General Meeting
Manorama Industries Limited announced the voting results of its postal ballot, confirming the appointment of Dr. Rohini Tiwari as a Non-Executive Independent Director.
Manorama Industries Other Announcement
Manorama Industries submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming dematerialization activities processed by its RTA.
Manorama Industries Capital Structure Change
Manorama Industries' board approved up to Rs.30 Crore in capital infusions across three wholly-owned subsidiaries. The funds target working capital and general corporate purposes in Benin, Togo and Ivory Coast.
- Value
- ₹30.00 Cr
Manorama Industries Annual General Meeting
Manorama Industries issued a postal ballot notice to appoint Dr. Rohini Tiwari as Non-Executive Independent Director. E-voting window runs September 19 to October 18, 2026.
Manorama Industries Management Change
Manorama Industries Limited has appointed Dr. Rohini Tiwari as a Non-Executive Independent Director, while Mudit Kumar Singh concluded his tenure on the board.
Manorama Industries Board Meeting Outcome
Manorama Industries approved the appointment of an additional director, postal ballot processes, and a combined ₹75 Crore capital infusion into six of its wholly owned subsidiaries.
- Value
- ₹75.00 Cr
Other fund raise announcements
All →Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.